CORZNasdaq,OTC,Nasdaq,NasdaqSEC EDGAREDGAR

Core Scientific, Inc./tx

Finance Services·DOVER, DE·FY end 12/31·CIK 1839341

Financials

5-year history · USD
MetricFY 2025FY 2024FY 2023FY 2022FY 2021Trend
Revenue$319.0M$510.7M$502.4M$640.3M
Gross Profit$37.9M$121.1M$123.5M$8.4M
Operating Income-$245.6M-$65.4M$9.0M-$2.1B-$5.2M
Net Income-$288.6M-$291.1M-$246.5M-$2.1B-$32.5M
Operating CF$278.3M$42.9M$65.1M$205.2M-$1.9M
Capex$729.0M$95.0M$16.2M$384.0M
Free Cash Flow-$450.8M-$52.1M$49.0M-$178.8M
Buybacks$0
Dividends
Gross Margin11.9%23.7%24.6%1.3%
Operating Margin-77.0%-12.8%1.8%-329.5%
Net Margin-90.5%-57.0%-49.1%-335.2%
FCF Margin-141.3%-10.2%9.7%-27.9%
R&D / Revenue2.3%1.4%4.2%
Effective Tax-0.2%-0.3%-0.3%0.8%
Debt / Equity
Buybacks / FCF0.0%

Peer comparison

Finance Services · 5 peers
CEO Pay Ratio
CORZ
171:1
RIOT
1,419:1
IREN
993:1
AXP
814:1
SOFI
248:1
CRCL
54:1
CEO total comp
CORZ
$23M
RIOT
$84M
IREN
$73M
AXP
$46M
SOFI
$30M
CRCL
$16M
Net Margin
CORZ
-90.5%
RIOT
-102.4%
IREN
17.4%
AXP
26.2%
SOFI
77.7%
CRCL
-2.5%